Fleming Laboratories Limited specializes in the manufacturing and supply of high-quality generic Active Pharmaceutical Ingredients (APIs) for the global pharmaceutical industry. The company emphasizes a sustainable manufacturing framework built on four key pillars: reducing carbon footprint through the use of renewable energy, conserving water by recovering and reusing effluent, minimizing waste through reduction, recycling, and reuse, and developing green initiatives. This commitment to sustainability reflects the company's dedication to environmentally responsible practices while maintaining high standards in pharmaceutical production.

The product pipeline of Fleming Laboratories includes a diverse range of APIs across various therapeutic categories, such as anti-histamines, muscle relaxants, pain management, anti-diarrheals, cardiovascular drugs, and treatments for osteoporosis. Each API is accompanied by detailed documentation, including regulatory approvals and compliance with international standards such as WHO GMP and EU-GMP. The company actively engages in regulatory filings, ensuring that its products meet the necessary requirements for distribution in multiple countries, thereby reinforcing its position as a reliable supplier in the pharmaceutical sector.

India

A Public limited firm in the business of manufacturing and supply of High quality Generic Active Pharmaceutical Ingredients (APIs) to the Global Pharmaceutical Industry since 1995.

Fleming Laboratories

Company Details